Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (281-290 of 768) with videos related to

Pageof 77
Sort By:
The American Journal of Medicine|August 1, 1988
Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancerD J Winston, L J Eron, M Ho, et al.
Blood|September 15, 1995
Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatmentD C Seong, H M Kantarjian, J Y Ro, et al.
Bone Marrow Transplantation|September 13, 2016
Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomesJ E Brammer, R M Saliba, J L Jorgensen, et al.
Bone Marrow Transplantation|November 18, 2008
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AMLR M Saliba, K V Komanduri, S Giralt, et al.
Bone Marrow Transplantation|March 30, 2004
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemiaP Mittal, R M Saliba, S A Giralt, et al.
Leukemia Research|June 14, 2016
Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cellsBenigno C Valdez, Jonathan E Brammer, Yang Li, et al.
Annals of Internal Medicine|July 1, 1986
Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trialR T Mitsuyasu, R E Champlin, R P Gale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemiaS A Giralt, H M Kantarjian, M Talpaz, et al.
Bone Marrow Transplantation|December 1, 1995
Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patientsD Przepiorka, K W Chan, R E Champlin, et al.
Leukemia & Lymphoma|March 17, 2016
Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cellsEsmeralda C Teo, Benigno C Valdez, Jie Ji, et al.
Pageof 77

Showing results (281-290 of 768) with videos related to

Sort By:
Pageof 77
The American Journal of Medicine|August 1, 1988
Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancerD J Winston, L J Eron, M Ho, et al.
Blood|September 15, 1995
Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatmentD C Seong, H M Kantarjian, J Y Ro, et al.
Bone Marrow Transplantation|September 13, 2016
Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomesJ E Brammer, R M Saliba, J L Jorgensen, et al.
Bone Marrow Transplantation|November 18, 2008
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AMLR M Saliba, K V Komanduri, S Giralt, et al.
Bone Marrow Transplantation|March 30, 2004
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemiaP Mittal, R M Saliba, S A Giralt, et al.
Leukemia Research|June 14, 2016
Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cellsBenigno C Valdez, Jonathan E Brammer, Yang Li, et al.
Annals of Internal Medicine|July 1, 1986
Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trialR T Mitsuyasu, R E Champlin, R P Gale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemiaS A Giralt, H M Kantarjian, M Talpaz, et al.
Bone Marrow Transplantation|December 1, 1995
Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patientsD Przepiorka, K W Chan, R E Champlin, et al.
Leukemia & Lymphoma|March 17, 2016
Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cellsEsmeralda C Teo, Benigno C Valdez, Jie Ji, et al.
Pageof 77